Plain-English translation of NCT07157670 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows 400 patients who have received an allogeneic hematopoietic stem cell transplant — a procedure used to treat serious blood cancers. The study tracks how patients' hearts respond over time using heart imaging, blood tests, and electrocardiograms. Researchers want to better understand which patients are at risk for heart complications and how to catch problems early.
Stem cell transplants and their conditioning treatments can damage the heart in both the short and long term, sometimes causing serious problems like heart attacks, abnormal rhythms, or heart failure. Current guidelines recommend monitoring patients' hearts, but doctors don't yet fully understand why some patients develop these complications or how to predict and prevent them. This study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You will have regular heart check-ups at the hospital where you are being treated for your transplant. These visits include heart ultrasounds (echocardiograms), heart rhythm recordings (electrocardiograms), and blood tests to measure heart damage markers. The study follows you over time to see how your heart responds to the transplant treatment and to identify early warning signs of problems.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
France